Nomo's figures of 13,000 users cannot be accuratly proved. You have to take into account advertising, promotions, commissions, etc., to arrive at an accurate figure. Anyway, doctor's can prescribe anything they wan't as a course of treatment. It does not matter if it is a twinkie. It does not need FDA approval. If it works, they will prescribe it. The studies, like I have pointed out before, will be sufficient to make claims for certain conditions. Do you think that a doctor, knowing that a product is available that does something no other drug can, that he would not prescribe it? In my opinion, he would be negligent in not precribing it. Anyway, as I said before, the sky is the limit on this stock. So many avenues for revenue. If just a couple come to fruition, smart investors will be very happy.
